Posted on behalf of Dr. Xinlai Cheng In the Department of Biochemistry, Chemistry and Pharmacy - Institute of Pharmaceutical Chemistry in the field of Medicinal Chemistry - Dr. Xinlai Cheng offers a position starting instantly of a PhD-Student/ Research Associate (E13 TV-G-U, 50 % part-time). limited up to 31.12.2022 (possible expansion to 31.12.2025). The salary grade is based on the job characteristics of the collective agreement applicable to Goethe University (TV-G-U). Link to job webpage - https://www.uni-frankfurt.de/81647683/Aktueller_Stellenmarkt_vom_08_Juli_2020.pdf Area of responsibility The work will be done in a multi-disciplinary research environment encompassing medicinal chemistry, stem cell and chemotherapy. The candidate will work at the Buchmann Institute for Molecular Life Sciences/Pharmaceutical Chemistry (Frankfurt am Main). The work will be performed in close collaboration with other research groups in Frankfurt, Heidelberg and Jena. We are looking for a PhD-student (graduate student) who is interested to work on a challenging project at the interface of chemistry, biochemistry and (stem) cell biology. The aim of our project is to identify new bioactive compounds and study the mechanism of action for regenerative medicine and cancer therapy. The candidate will be offered the opportunity to do self-directed research and develop further scientific qualification. Employment requirements Applicants should have a master degree (or equal) in organic chemistry and medicinal chemistry. The candidate should have experience in organic synthesis, and in particular heterocyclic compounds synthesis. Knowledge on the application of novel synthetic methodologies and PROTAC will be advantageous. High level knowledge and good communication skills in English and German are expected. In order to increase the proportion of women in research, we particularly encourage women to apply for this position. Disabled people will be considered preferentially in the case of equal aptitude. The planned research will be carried out in an international research environment at the Life Science Campus Riedberg. Interested candidates are encouraged to send applications until July, 22th 2020 to the following e-mail address: Dr. rer.nat.habil. Xinlai Cheng, cheng@pharmchem.uni-frankfurt,de, Goethe-Universität, Buchmann Institute for Molecular Life Sciences; Pharmaceutical Chemistry; Max-von-Laue-Strasse 15. R. 3.652 ; 60438 Frankfurt am Main. Best, Dr. Xinlai Cheng To unsubscribe from the CCP4BB list, click the following link: |